# Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH)

> **NCT03844594** · PHASE3 · UNKNOWN · sponsor: **Ministry of Science and Technology of the People´s Republic of China** · enrollment: 220 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Eptifibatide Injection

## Key facts

- **NCT ID:** NCT03844594
- **Lead sponsor:** Ministry of Science and Technology of the People´s Republic of China
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-06
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-12-31
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2019-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03844594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03844594, "Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03844594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*